Associated Papers
Biobank-scale genetic characterization of Alzheimer's disease and related dementias across diverse ancestries.
Khani M et al.
Nature Communications, 2025
40813364 (PubMed )
Supplement: 41467_2025_62108_MOESM4_ESM.xlsx › Supplementary_Data_2
Genetic and Metabolic Factors of Familial Dysbetalipoproteinemia Phenotype: Insights from a Cross-Sectional Study.
Blokhina AV et al.
International Journal of Molecular Sciences, 2025
The Promise of Exome Sequencing for the Differential Diagnosis of Late-Onset End-Stage Renal Disease in Turkish Cypriots.
Kazan HH et al.
Cureus, 2025
Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features.
Matsunaga A et al.
Journal of Atherosclerosis and Thrombosis, 2025
Spectrum and Prevalence of Rare APOE Variants and Their Association with Familial Dysbetalipoproteinemia.
Blokhina AV et al.
International Journal of Molecular Sciences, 2024
Corrigendum to "APOE gene variants in primary dyslipidemia" [Atherosclerosis (2021 Jul) 328 11-22].
Abou Khalil Y et al.
Atherosclerosis, 2023
Genetics of Alzheimer's disease: an East Asian perspective.
Miyashita A et al.
Journal of Human Genetics, 2023
In silico analyses of deleterious missense SNPs of human apolipoprotein E3.
Pires AS et al.
Scientific Reports, 2017
28559539 (PubMed )
Supplement: 41598_2017_1737_MOESM1_ESM.docx
Structural and phylogenetic approaches to assess the significance of human Apolipoprotein E variation.
Corbo RM et al.
Molecular Genetics and Metabolism, 2006
Apolipoprotein A-IV polymorphisms and diet-gene interactions.
Weinberg RB
Current Opinion in Lipidology, 2002
Select a paper to view details